SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-21-001017
Filing Date
2021-08-17
Accepted
2021-08-17 16:45:27
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 55501
2 JOINT FILING AGREEMENT exhibit99-1.htm EX-99.1 6704
  Complete submission text file 0000929638-21-001017.txt   63763
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 211183365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022
Business Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022 646-395-3931
Lind Global Macro Fund LP (Filed by) CIK: 0001773156 (see all company filings)

IRS No.: 830854952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G